XML 51 R40.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2012
Stock-Based Compensation  
Schedule of the Company's issuance of common stock under the 2005 Employee Stock Purchase Plan
  Fiscal Years  
 
  2012   2011   2010  

Common shares issued

    325,270     272,767     338,656  

Average price

  $ 20.48   $ 22.58   $ 17.11  
Schedule of stock-based compensation

Stock-based compensation expense related to stock options, SARs, ESPP shares, and RSUs was recognized in Advent's consolidated statement of operations for the periods presented as follows (in thousands):

 
  Fiscal Years  
 
  2012   2011   2010  
 
  Options,
SARs &
ESPP
  RSUs   Total   Options,
SARs &
ESPP
  RSUs   Total   Options,
SARs &
ESPP
  RSUs   Total  

Statement of operations classification

                                                       

Cost of recurring revenues

  $ 1,432   $ 973   $ 2,405   $ 1,105   $ 1,049   $ 2,154   $ 1,066   $ 708   $ 1,774  

Cost of non-recurring revenues

    642     594     1,236     753     561     1,314     804     337     1,141  
                                       

Total cost of revenues

    2,074     1,567     3,641     1,858     1,610     3,468     1,870     1,045     2,915  

Sales and marketing

   
4,881
   
2,284
   
7,165
   
4,324
   
1,981
   
6,305
   
4,141
   
1,725
   
5,866
 

Product development

    2,952     2,869     5,821     2,348     2,790     5,138     2,856     2,344     5,200  

General and administrative

    2,437     1,737     4,174     2,443     1,784     4,227     3,213     1,236     4,449  
                                       

Total operating expenses

    10,270     6,890     17,160     9,115     6,555     15,670     10,210     5,305     15,515  
                                       

Total stock-based employee compensation expense

  $ 12,344   $ 8,457   $ 20,801   $ 10,973   $ 8,165   $ 19,138   $ 12,080   $ 6,350   $ 18,430  
                                       

Tax effect on stock-based employee compensation

    (4,763 )   (3,324 )   (8,087 )   (4,303 )   (3,169 )   (7,472 )   (5,592 )   (2,568 )   (8,160 )
                                       

Effect on net income from continuing operations, net of tax

  $ 7,581   $ 5,133   $ 12,714   $ 6,670   $ 4,996   $ 11,666   $ 6,488   $ 3,782   $ 10,270  
                                       
Schedule of assumptions used in determining the fair value of stock-based awards
 
  Fiscal Years
 
  2012   2011   2010

Stock Options and SARs

           

Risk-free interest rate

  0.6% - 1.2%   0.9% - 2.4%   1.3% - 2.7%

Volatility

  38.4% - 42.9%   36.0% - 42.8%   35.2% - 38.8%

Expected life

  4.02 - 5.50 years   5 years   4 - 5 years

Expected dividends

  None   None   None

Employee Stock Purchase Plan*

           

Risk-free interest rate

  0.1%   0.1% - 0.2%   0.2%

Volatility

  31.0% - 48.3%   28.6% - 48.3%   28.8% - 29.9%

Expected life

  6 months   6 months   6 months

Expected dividends

  None   None   None

*
The ESPP periods begin every six months on December 1 and June 1 of each year.
Schedule of Stock option and SAR activity

The Company's stock option and SAR activity for the periods presented is as follows (in thousands, except weighted average exercise price):

 
  Fiscal Years  
 
  2012   2011   2010  
 
  Number of
Shares
  Weighted
Average
Exercise
Price
  Number of
Shares
  Weighted
Average
Exercise
Price
  Number of
Shares
  Weighted
Average
Exercise
Price
 

Outstanding at beginning of year

    7,029   $ 18.01     6,780   $ 15.73     7,886   $ 14.57  

Options and SARs granted

    1,895   $ 24.92     1,469   $ 26.72     1,041   $ 22.13  

Options and SARs exercised

    (972 ) $ 15.60     (1,032 ) $ 14.47     (1,795 ) $ 13.91  

Options and SARs canceled

    (284 ) $ 23.63     (188 ) $ 22.96     (352 ) $ 18.05  
                           

Outstanding at end of year

    7,668   $ 19.82     7,029   $ 18.01     6,780   $ 15.73  
                           

Exercisable at end of year

    4,575   $ 16.55     4,355   $ 14.65     4,278   $ 13.37  
                           
Schedule of weighted average grant date fair value and intrinsic value of stock options and SARs and cash received from options exercised

The weighted average grant date fair value of options and SARs granted for the total Company, total intrinsic value of options and SARs exercised and cash received from options exercised during the periods presented were as follows (in thousands, except weighted average grant date fair value):

 
  Fiscal Years  
 
  2012   2011   2010  

Options and SARs

                   

Weighted average grant date fair value

  $ 8.88   $ 9.35   $ 7.64  

Total intrinsic value of awards exercised

  $ 10,086   $ 13,612   $ 18,875  

Options

                   

Cash received from exercises

  $ 5,173   $ 7,189   $ 14,020  
Schedule of options and SARs outstanding and exercisable by exercise price

  Options and SARs Outstanding   Options and SARs
Exercisable
 
Exercise Price
  Number
of Shares
(in thousands)
  Weighted
Average
Remaining
Contractual
Life (in years)
  Weighted
Average
Exercise
Price
  Number
Exercisable
(in thousands)
  Weighted
Average
Exercise
Price
 

$6.96 - $9.13

    877     1.53   $ 9.04     877   $ 9.04  

$9.35 - $9.36

    77     1.05   $ 9.35     77   $ 9.35  

$9.48 - $14.09

    942     2.66   $ 12.02     917   $ 12.05  

$14.16 - $16.97

    770     5.29   $ 15.96     701   $ 15.94  

$17.00 - $20.88

    911     4.88   $ 19.55     830   $ 19.50  

$21.09 - $21.75

    1,170     8.47   $ 21.42     373   $ 21.71  

$21.90 - $26.73

    742     7.45   $ 24.53     374   $ 24.24  

$26.80

    1,057     9.31   $ 26.80       $  

$26.85

    11     7.87   $ 26.85     5   $ 26.85  

$26.91

    918     8.06   $ 26.91     372   $ 26.91  

$27.02 - $30.15

    193     8.54   $ 27.50     49   $ 27.68  
                       

As of December 31, 2012

    7,668     6.11   $ 19.82     4,575   $ 16.55  
                       

Expected to vest at December 31, 2012

    7,295     5.95   $ 19.57              
                           
Schedule of equity awards available for grant

The equity awards available for grant for the periods presented were as follows (in thousands):

 
  Fiscal Years  
 
  2012   2011   2010  

Beginning balance

    4,545     6,622     5,087  

Awards authorized

    1,915         3,002  

Options and SARs granted

    (1,895 )   (1,469 )   (1,041 )

Options and SARs canceled

    284     188     352  

Options expired

        (10 )    

RSUs granted

    (520 )   (489 )   (452 )

RSUs canceled

    98     94     62  

RSU adjustment(1)(2)

    (272 )   (391 )   (388 )
               

Ending balance

    4,155     4,545     6,622  
               

(1)
Effective with our 2002 Stock Plan amended on April 1, 2012, awards of restricted stock, restricted stock units, performance shares or performance units reduce the number of shares available under the Plan by 1.79 shares for each share covered by such awards.
(2)
Effective with our 2002 Stock Plan amended on April 1, 2010, awards of restricted stock, restricted stock units, performance shares or performance units reduce the number of shares available under the Plan by 1.99 shares for each share covered by such awards.
Summary of RSU Activity
 
  Fiscal Years  
 
  2012   2011   2010  
 
  Number of
Shares
(in thousands)
  Weighted
Average
Grant Date
Fair Value
  Number of
Shares
(in thousands)
  Weighted
Average
Grant Date
Fair Value
  Number of
Shares
(in thousands)
  Weighted
Average
Grant Date
Fair Value
 

Outstanding and unvested at beginning of period

    1,253   $ 16.51     1,308   $ 19.58     1,369   $ 18.17  

RSUs granted

   
520
 
$

25.69
   
489
 
$

26.75
   
452
 
$

22.05
 

RSUs vested

    (402 ) $ 21.36     (450 ) $ 35.35     (451 ) $ 17.85  

RSUs canceled

    (98 ) $ 23.82     (94 ) $ 22.21     (62 ) $ 18.99  
                           

Outstanding and unvested at end of period

    1,273   $ 18.16     1,253   $ 16.51     1,308   $ 19.58